daily oral administration of ethinyl estradiol ( 0.02 , 0.2 , or 2.0 mg/kg of body weight ) to pregnant jc1 : icr mice resulted in ovotestis and intra-abdominal testis with persistent mullerian duct and wolffian duct in male fetuses and ovarian hypoplasia in female fetuses when it was given from day 11 through day 17 of gestation ( before gonadal differentiation in the fetus ) .
C0015011
ethinyl estradiol
C0032961
gestation